来自iPSCs的基因工程巨细胞用于自我调节的抗炎生物药物的输送
Molly Klimak1,2,3,4, Farshid Guilak1,2,3,4
1Department of Orthopaedic Surgery, Washington University, St. Louis, MO 63110, USA.
Journal of tissue engineering and regenerative medicine
|April 4, 2024
概括
研究人员设计了干细胞衍生的巨细胞,为慢性炎症疾病提供抗炎药物. 这种新型的巨细胞疗法提供了有针对性的治疗,有可能减少与目前治疗诸如类风湿性关节炎等疾病相关的副作用.
科学领域:
- 免疫学 免疫学 免疫学
- 干细胞生物学 干细胞生物学
- 生物技术是生物技术.
背景情况:
- 类风湿性关节炎涉及由失调的细胞因子信号传递驱动的慢性炎症.
- 目前用于类风湿性关节炎的治疗方法通常具有有限的有效性和显著的副作用,由于高剂量和非目标效应.
- 巨细胞通过产生炎症性细胞因子,在加速慢性炎症方面发挥关键作用.
研究的目的:
- 为了设计一种新的诱导多能干细胞 (iPSC) 衍生巨细胞 (iMAC) 针对性药物输送.
- 开发一种用于慢性炎症疾病的自调节治疗系统.
- 调查iMACs在响应TNF-α时提供可溶性TNF受体1 (sTNFR1) 的潜力.
主要方法:
- 用17天的优化协议将小鼠iPSC分化为巨细胞 (iMAC).
- 使用各种炎症和免疫调节刺激,证实了巨细胞功能和表型.
- 工程化iMACs被评估其产生sTNFR1响应TNF-α的能力.
主要成果:
- 已成功将iPSCs分化为功能性巨细胞 (iMACs).
- 经过工程设计的iMAC显示,在对TNF-α的反应中,sTNFR1的自我调节产生.
- 由iMACs产生的sTNFR1有效抑制了炎症信号传递.
结论:
- 工程化iMACs代表了一个有前途的基于巨细胞的药物输送系统.
- 这种新的治疗方法具有治疗各种慢性炎症疾病的潜力.
- 自动调节的输送系统提供了有针对性的治疗,有可能减少非目标效应.
更多相关视频
06:12Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders
Published on: September 6, 2024
1.3K
10:10Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
8.7K
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
